Analyst Ratings for Teva Pharma (TEVA) [Neutrals]
TEVA Rating Summary
TEVA Price Target Summary
- Highest: $65.00 (Standpoint Research)
- Lowest: $42.00 (Barclays)
- Average: $47.50
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$47.50 (+20.9%)
Avg. $ Target:
$47.50 (+20.9%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/18/2013 | Wells Fargo | Downgrade | Market Perform (Outperform) |
44.00 (46.50) |
40.82 | 39.30 | -3.72% | Details |
| 2/25/2013 | Argus | Downgrade | Hold (Buy) |
N/A (N/A) |
38.08 | 39.30 | 3.2% | Details |
| 2/8/2013 | Canaccord Genuity | Downgrade | Hold (Buy) |
45.00 (50.00) |
37.96 | 39.30 | 3.53% | Details |
| 12/12/2012 | Leerink Swann | Downgrade | Market Perform (Outperform) |
44.50 (47.50) |
41.67 | 39.30 | -5.69% | Details |
| 12/3/2012 | UBS | Downgrade | Neutral (Buy) |
N/A (N/A) |
40.35 | 39.30 | -2.6% | Details |
| 11/30/2012 | Buckingham Research | Downgrade | Neutral (Buy) |
N/A (N/A) |
40.22 | 39.30 | -2.29% | Details |
| 9/18/2012 | Guggenheim | New Coverage | Neutral (N/A) |
45.00 (N/A) |
38.10 | 39.30 | 3.15% | Details |
| 5/23/2012 | Auriga | New Coverage | Hold (N/A) |
45.00 (N/A) |
39.18 | 39.30 | 0.31% | Details |
| 5/10/2012 | Needham & Company » Updated 8/3/2012 |
Upgrade | Hold (N/A) |
N/A (N/A) |
42.19 | 39.30 | -6.85% | Details |
| 2/6/2012 | Morgan Stanley | Downgrade | Equalweight (N/A) |
N/A (N/A) |
45.71 | 39.30 | -14.02% | Details |
| 12/9/2011 | Barclays » Updated 5/25/2012 |
New Coverage | Equalweight (N/A) |
42.00 (N/A) |
39.74 | 39.30 | -1.11% | Details |
| 12/1/2011 | SunTrust Robinson Humphrey | Downgrade | Neutral (N/A) |
N/A (N/A) |
39.61 | 39.30 | -0.78% | Details |
| 10/24/2011 | Piper Jaffray | Downgrade | Neutral (N/A) |
45.00 (N/A) |
39.16 | 39.30 | 0.36% | Details |
| 9/22/2011 | Goldman Sachs » Updated 2/12/2013 |
New Coverage | Neutral (N/A) |
42.00 (N/A) |
36.63 | 39.30 | 7.29% | Details |
| 8/2/2011 | Oppenheimer » Updated 8/3/2012 |
Downgrade | Perform (N/A) |
N/A (N/A) |
43.76 | 39.30 | -10.19% | Details |
